These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9757793)

  • 1. Newer-generation fluoroquinolone antibiotics.
    Hedge DD
    S D J Med; 1998 Sep; 51(9):349-50. PubMed ID: 9757793
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolone use in children.
    Sabharwal V; Marchant CD
    Pediatr Infect Dis J; 2006 Mar; 25(3):257-8. PubMed ID: 16511391
    [No Abstract]   [Full Text] [Related]  

  • 3. Common questions about the newer fluoroquinolone antibiotics.
    North DS
    Nurse Pract; 1999 Mar; 24(3):124-7. PubMed ID: 10100244
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of fluoroquinolones: practical considerations.
    Ponte CD; Fisher MA
    Am Fam Physician; 1993 Apr; 47(5):1243-9. PubMed ID: 8465719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone approved for cattle.
    J Am Vet Med Assoc; 1998 Sep; 213(6):779. PubMed ID: 9743711
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.
    Sahm DF; Critchley IA; Kelly LJ; Karlowsky JA; Mayfield DC; Thornsberry C; Mauriz YR; Kahn J
    Antimicrob Agents Chemother; 2001 Jan; 45(1):267-74. PubMed ID: 11120976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steps forward and backward within the fluoroquinolone class.
    Hedge DD
    S D J Med; 2000 Apr; 53(4):137-8. PubMed ID: 10790988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Impact of fluoroquinolone use on multidrug-resistant bacteria emergence].
    Nseir S; Ader F; Marquette CH; Durocher A
    Pathol Biol (Paris); 2005; 53(8-9):470-5. PubMed ID: 16176863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoroquinolones: considerations for future use.
    Congeni BL; Thomson RB
    Pediatr Infect Dis J; 2002 Apr; 21(4):345-6. PubMed ID: 12075768
    [No Abstract]   [Full Text] [Related]  

  • 15. Trovafloxacin: fourth generation fluoroquinolone.
    McNabb J; Nicolau D; Quintiliani R; Nightingale C
    Conn Med; 1998 Aug; 62(8):483-7. PubMed ID: 9753805
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic therapy for musculoskeletal infections.
    Mader JT; Wang J; Calhoun JH
    Instr Course Lect; 2002; 51():539-51. PubMed ID: 12064145
    [No Abstract]   [Full Text] [Related]  

  • 17. The newer fluoroquinolones.
    O'Donnell JA; Gelone SP
    Infect Dis Clin North Am; 2004 Sep; 18(3):691-716, x. PubMed ID: 15308282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral antibiotic treatment of chronic osteomyelitis in adults].
    Javaloyas de Morlius M
    Med Clin (Barc); 1996 Oct; 107(12):472-6. PubMed ID: 9036258
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of newer fluoroquinolones.
    Stein GE
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S19-24. PubMed ID: 8953102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining fluoroquinolone class efficacy: review of influencing factors.
    Scheld WM
    Emerg Infect Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12533274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.